Status:
UNKNOWN
Towards HOMe-based Albuminuria Screening: an Implementation Study Testing Two Approaches
Lead Sponsor:
University Medical Center Groningen
Collaborating Sponsors:
Dutch Kidney Foundation
E-Zorg B.V. / KPN Health
Conditions:
Albuminuria
Eligibility:
All Genders
45-80 years
Phase:
NA
Brief Summary
Chronic Kidney Disease (CKD) is a worldwide major public health problem that is associated with an increased incidence of kidney failure and cardiovascular events, that lead a high burden for affected...
Detailed Description
Chronic kidney disease (CKD) is a worldwide major public health problem that is associated with an increased incidence of kidney failure and cardiovascular disease (CVD). To tackle this burden, screen...
Eligibility Criteria
Inclusion
- Age 45 to 80 years.
- Living in the municipality of Breda, The Netherlands.
- Not institutionalised.
Exclusion
- Younger than 45 years or older than 80 years.
- Not living in the municipality of Breda, The Netherlands.
- Institutionalised.
- A random sample of 15.032 subjects will be drawn from the population aged 45-80 years from the municipality of Breda by the Dutch Central Bureau for Statistics (CBS).
Key Trial Info
Start Date :
November 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2022
Estimated Enrollment :
15032 Patients enrolled
Trial Details
Trial ID
NCT04295889
Start Date
November 14 2019
End Date
July 1 2022
Last Update
April 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Medical Centre Groningen
Groningen, Netherlands, 9700 RB